The partnership will allow easier access to medications
Novo Nordisk has announced its partnership with online pharmacy platform Pocketpills to help improve access to safe and reliable medications.
The collaboration aims to address the demand for a more convenient access without any stigma to treatments for chronic diseases from the comfort of one’s home, such as the management of type 2 diabetes and obesity.
Novo Nordisk Canada Inc. President Vince Lamanna expressed the company’s commitment to supporting optimal patient care and innovation, while also noting the evolving landscape of medical care access.
“This collaboration represents a roadmap for the future of healthcare; advancing care and improving health outcomes for millions of Canadians,” said Lamanna.
Patients that are prescribed Ozempic or Wegovy will be able to access a healthcare management approach where their medication can be delivered across Canada. They will also be able to connect confidentially and directly to licensed pharmacists either through text or email.
“This partnership with Pocketpills allows us to support our patients with a streamlined process for accessing their medications from home. We recognize the significant stigma people face when living with type 2 diabetes and obesity, which can make accessing traditional care challenging,” said Lamanna.
“Our mission has always been to break down barriers that prevent Canadians from getting the care they need - whether that's geographic limitations, time constraints, or the stigma often associated with managing chronic conditions,” said Pocketpills CEO Raj Gulia.
“This partnership allows us to extend that accessibility to even more Canadians who deserve convenient, judgment-free healthcare,” said Gulia.
Novo Nordisk was one of the developers of GLP-1 drugs, which had been part of the solution in treating obesity among patients that had a body mass index (BMI) of 30 or higher. Recently, the World Health Organization (WHO) has recommended the use of these weight-loss drugs for obesity treatments among adults.
